Regal Assets Analytics

WDLangbein

About Bill Langbein

Before starting SanaCurrents, William (Bill) Langbein spent more than 20 years as a life science business journalist, with stops at California Medicine, In Vivo and Reuters Health. During that time, he wrote on genomic discoveries, the transition of the pharmaceutical companies to rely more on biologics, and the dawn of precision medicine, through which most drug developers came to recognize a one-drug-for-all approach would no longer work. One constant truth he learned is smaller companies deliver the most innovation and highest value to patients and investors. Yet because of the inherent volatility of biopharma and medical devices, small companies typically fly under the radar of investors. The emergence of precision medicine, however, reduces the volatility of small cap companies and increases the potential for strong returns. SanaCurrents was founded to identify the undervalued therapies that would benefit patients and investors the most.

Oragenics, Inc Therapeutics (OGEN) Probability Sentiment

By |2020-02-16T19:05:05-05:00February 15th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Oragenics Inc. (NYSE:OGEN) Probability Sentiment [...]

Bioxcel Rockets After Suntrust Upgrade; Agile Volatile Ahead Of FDA Decision

By |2020-02-16T19:06:20-05:00February 14th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: , |

BioXcel Therapeutics (NASDAQ:BTAI) soared this morning to about $38 per [...]

vTv Therapeutics (VTVT) Nearly Doubles in Monday trading after positive phase II data

By |2020-02-14T12:41:35-05:00February 10th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

Shares of vTv Therapeutics (NASDAQ:VTVT) soared Monday morning, briefly eclipsing [...]

Twist Turns Higher after Settlement with Agilent

By |2020-02-14T12:44:18-05:00February 7th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Twist Bioscience Corporation (NASDAQ:TWST) moved higher in the last 24 [...]

Swedish Orphan Biovitrum AB Probability Sentiment

By |2020-02-01T12:01:31-05:00January 31st, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Swedish Orphan Biovitrum AB (OTCPINK:BIOVF) (STO:SOBI) Probability Sentiment [...]

Acceleron Soars, Another Catalyst on the Way, And a Few Changes to Your SanaCurrents Home page

By |2020-02-15T11:38:23-05:00January 31st, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|

Acceleron Soars Shares of Acceleron Pharma (NASDAQ: XLRN) climbed nearly [...]

vTv Therapeutics Inc. Probability Sentiment

By |2020-02-15T14:39:29-05:00January 24th, 2020|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

vtv Therapeutics Inc. (NASDAQ:VTVT) Probability Sentiment [...]